Physician review
Prescription decisions begin with medical-history and contraindication review by Dr. Anjmun Sharma, MD.
✓ Medically reviewed by Dr. Anjmun Sharma, M.D., Updated May 2026
A Mounjaro Alternative That Won't Break the Bank
The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary.
mounjaro alternativemounjaro cliniccheaper than mounjaromounjaro without insurancealternatives to mounjaro
Quick answer
The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary. New Hope Weight Loss is not affiliated with Eli Lilly or the Mounjaro brand; we offer cash-pay compounded tirzepatide from $233 per month with no insurance required and a $119 telehealth consultation to start.
Important: Compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical. Eligibility and results vary.
Costs less than a coffee and a pastry.
A coffee and a pastry~$9/day
Your weight-loss plan$7.70/day$54/week
$233 a month, physician-supervised, no insurance needed.
Why People Look for a Mounjaro Alternative
Mounjaro® is a registered trademark of Eli Lilly and Company and is approved by the FDA for specific uses. But for many people it's hard to get: list prices can exceed $1,000/month without insurance, coverage is inconsistent, and the 2024-2025 shortages showed how unreliable access can be. That's why so many search for a more accessible alternative.
New Hope Weight Loss is not affiliated with Eli Lilly and Company. The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary.
How the Compounded Option Compares
| Brand-name Mounjaro | Compounded Tirzepatide at NHWL | |
|---|---|---|
| Active ingredient | Tirzepatide | Label identifies tirzepatide; separate compounded product |
| Typical monthly cost | $1,000+ (no insurance) | from $233/mo |
| Physician supervision | Varies | Always, Dr. Sharma |
| FDA-approved product | Yes | No (compounded) |
| Insurance required | Often | Never |
Compounded medications are not FDA-approved products, are not brand-identical, and results vary. Any prescription requires individualized medical review and lawful pharmacy fulfillment. Dr. Sharma will tell you honestly whether you're a good candidate.
What You Pay at New Hope Weight Loss
- $119 one-time, Dr. Sharma's review + first prescription.
- from $699 for a 3-month plan = $233/month.
- $199 one-month Skeptics Trial (compounded semaglutide) if you want to start small.
HSA/FSA accepted. Klarna and Affirm financing available. No insurance, ever.
Estimate Your Savings
Frequently asked questions
Is there a cheaper alternative to Mounjaro?
The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary. Compounded medications are not FDA-approved and are not identical to the brand, but they are a legal, supervised, more accessible option.
Can I get Mounjaro without insurance?
Brand-name Mounjaro typically requires insurance or out-of-pocket payment exceeding $1,000/month. New Hope Weight Loss never requires insurance, compounded tirzepatide is cash-pay from $233/month with HSA/FSA accepted.
Is the compounded version the same as Mounjaro?
The dispensing pharmacy label identifies the compounded preparation as tirzepatide. It is a different product from FDA-approved brand products, is not FDA-approved or brand-identical, and results vary. Any prescription requires Dr. Sharma's review and depends on lawful pharmacy fulfillment for the patient's location.
How do I switch from Mounjaro to the compounded option?
Take our 2-minute quiz and complete the medical intake form. Tell Dr. Sharma about your current dose and history; she'll determine the right starting plan and supervise the transition.
Transparent pricing
$233/month
About $7.70 a day, less than a coffee and a pastry
A fraction of brand-name GLP-1 list prices, which often run $900 to $1,300 or more a month.
- Licensed U.S. physician, supervised the whole way
- Compounded tirzepatide included
- Only if a prescription is approved and the dispensing pharmacy can fulfill it for your location, the pharmacy confirms packaging and shipping details before fulfillment
- Ongoing dose adjustments and support
- No insurance needed, HSA and FSA plus financing accepted
$119 one-time to get started with your physician consultation.
Medical disclaimer: Individual results may vary. GLP-1 medications require a physician prescription and ongoing supervision. Clinical trial results cited are averages; not all patients achieve the same outcomes. Eligibility is determined during the medical consultation. This information does not replace professional medical advice.
New Hope Weight Loss | 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.
What Mounjaro Is Approved to Treat, and Why Its Label Is Not Zepbound's
Mounjaro and Zepbound are both Eli Lilly products and both contain tirzepatide, but they were approved under two separate FDA labels, and that difference matters when you are comparing options.
Mounjaro's FDA indication is glycemic control. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. Weight reduction is not on Mounjaro's label at all. Chronic weight management, and moderate to severe obstructive sleep apnea in adults with obesity, sit on Zepbound's label instead. Mounjaro is also the only one of the two whose indication reaches pediatric patients, down to age 10, and only for type 2 diabetes.
Pharmacologically, tirzepatide is a GIP receptor and GLP-1 receptor agonist, so it acts at two incretin receptors rather than the single GLP-1 receptor that semaglutide targets. Mounjaro is a once-weekly subcutaneous injection, and its label carries a boxed warning for risk of thyroid C-cell tumors, with contraindications in people who have a personal or family history of medullary thyroid carcinoma or MEN 2.
All of the above describes Eli Lilly's FDA-approved Mounjaro. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company, and New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Eli Lilly. None of it describes the compounded tirzepatide prescribed through New Hope Weight Loss and prepared by a licensed pharmacy, which is not FDA-approved, is not brand-identical, has not undergone FDA premarket review, and produces results that vary. Dr. Sharma assesses candidacy individually.
What is Mounjaro actually FDA-approved to treat?
Mounjaro is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. That is a blood-sugar indication, not a weight-loss one, and its label carries no weight-management use. The compounded tirzepatide prescribed through New Hope Weight Loss is not FDA-approved for any indication, is not brand-identical, and results vary.
Mounjaro and Zepbound both contain tirzepatide, so why is only one of them approved for weight?
Eli Lilly brought them forward as two separate products with separate clinical programs, so each carries its own FDA label. Mounjaro's label covers glycemic control in type 2 diabetes, including pediatric patients 10 and older. Zepbound's label covers chronic weight management and moderate to severe obstructive sleep apnea in adults with obesity. Same molecule, different approved uses and different studied populations. Neither label describes a compounded preparation.
Does the compounded tirzepatide at New Hope come with Mounjaro's FDA label or its diabetes indication?
No. Mounjaro's Prescribing Information describes Eli Lilly's FDA-approved product only, including its boxed warning for thyroid C-cell tumor risk. A compounded preparation is a different product. It is not FDA-approved, not brand-identical, has not undergone FDA premarket review for safety, effectiveness or quality, and results vary. Dr. Sharma reviews your history and contraindications individually, and any prescription depends on lawful pharmacy fulfillment for your location.